AIS Healthcare

At AIS Healthcare, we are committed to advancing care quality through innovative solutions that empower providers and support patients. Our dual divisionsAdvanced Infusion Care (AIC) and Targeted Drug Delivery (TDD)specialize in delivering personalized treatments for complex conditions. AIC provides in-home immunoglobulin therapy, Alpha-1 therapy, and outpatient infusion center services, utilizing a Center of Excellence approach to prioritize patient outcomes. TDD focuses on patient-specific compounded medications for intrathecal infusion pumps, produced in state-of-the-art 503A pharmacies that exceed industry standards. With over 300 skilled nurses nationwide, we ensure high-quality care through experienced registered nurses and nurse practitioners.

Dually accredited by URAC and the Accreditation Commission for HealthCare, we uphold rigorous quality standards while responding proactively to challenges like the COVID-19 pandemic. Our financial assistance programs and billing support reflect our dedication to accessible care, and our recent expansion into Phoenix, AZ, underscores our growing national footprint. We partner with Premier, Inc. to enhance medication access and maintain transparency in our operations. While discontinuing certain ophthalmic products in 2022, we remain focused on core services that improve patient quality of life. Through every initiative, we strive to do more than expected, ensuring life-changing outcomes for those we serve.